Valuation: Ovation Science Inc.

Market Cap 1.15M 821K 737K 680K 617K 77.99M 1.17M 8.16M 3.24M 40.88M 3.08M 3.02M 130M P/E 2024
-2.68x
P/E 2025 -2.26x
Enterprise Value 1.36M 971K 872K 805K 730K 92.25M 1.38M 9.65M 3.83M 48.35M 3.65M 3.57M 153M EV / Sales 2024
13.2x
EV / Sales 2025 25.7x
Free-Float
76.96%
Yield 2024 *
-
Yield 2025 -
1 day+50.00%
3 months+50.00%
6 months+20.00%
Current year-25.00%
Current year 0.02
Extreme 0.015
0.04
1 year 0.02
Extreme 0.015
0.05
3 years 0.01
Extreme 0.01
0.08
5 years 0.01
Extreme 0.01
0.1
10 years 0
Extreme 0
0.65
Manager TitleAgeSince
Director of Finance/CFO 63 30/10/2023
Chief Executive Officer 77 04/10/2017
Director of Finance/CFO 60 20/10/2026
Director TitleAgeSince
Director/Board Member 77 04/10/2017
Director/Board Member 63 04/10/2017
Director/Board Member 86 02/02/2018
Date Insider Type Main position Quantity % Market Cap. Importance
4/7/25 A Buy

Director

100,000 0.2642%
1/31/25 A Other

Director

0 0%
1/31/25 A Buy

Director

100,000 0.2642%
Change 5-day change 1-year change 3-year change Capi.($)
+50.00%-.--%-33.33%+50.00% 821K
-0.01%+1.67%+5.34%+6.83% 369B
-1.50%+4.42%+14.36%+8.06% 255B
-2.05%-0.58%-8.02%+10.28% 140B
-0.43%-1.48%+19.29%+24.55% 73.48B
+0.11%+6.28%+29.60% - 52.06B
-0.12%-2.02%-27.71%-26.84% 44.97B
+0.82%+5.38%+10.61%-14.64% 39.2B
-0.23%+1.84%+33.63%+4.02% 37.32B
-0.20%+2.14%-9.73%-8.87% 36.28B
Average +4.68%+1.11%+3.40%+5.93% 104.77B
Weighted average by Cap. -0.63%+1.68%+7.20%+5.90%

Financials

2024 2025
Net sales 113K 80.61K 72.34K 66.8K 60.57K 7.66M 115K 801K 318K 4.01M 303K 296K 12.73M 67.89K 48.33K 43.38K 40.05K 36.32K 4.59M 68.72K 480K 191K 2.41M 181K 178K 7.63M
Net income -456K -325K -292K -269K -244K -30.85M -462K -3.23M -1.28M -16.17M -1.22M -1.19M -51.28M -631K -449K -403K -372K -338K -42.69M -639K -4.47M -1.77M -22.38M -1.69M -1.65M -70.96M
Net Debt 265K 189K 169K 156K 142K 17.93M 268K 1.88M 745K 9.4M 709K 694K 29.81M 211K 150K 135K 124K 113K 14.25M 213K 1.49M 592K 7.47M 563K 551K 23.69M
Projected Income Statement - Annual - Ovation Science Inc.
Logo Ovation Science Inc.
Ovation Science Inc. is a Canada-based drug development company. The Company develops topical and transdermal cannabidiol (CBD)/ tetrahydrocannabinol (THC) and other cannabinoid products which are out-licensed and also distributed under its own brands; ARLO CBD Beauty and InVibe MD (wellness line); all powered by its patented Invisicare skin delivery technology. The Company manufactures, distributes, sells, markets, sub-licenses and promotes products formulated with Invisicare, containing cannabinoids, hemp seed oil or synthetic derivatives of cannabis. The Company has developed topical and transdermal creams and lotions made with CBD, THC and combinations thereof plus hemp seed oil. Invisicare is a patented polymer-based technology for topical and transdermal skincare products. ARLO CBD Beauty offers science-based skincare solutions. Invibe MD offers a health and wellness product line infused with hemp-derived CBD and developed using Invisicare drug delivery technology.
Employees
-
  1. Stock Market
  2. Stocks
  3. OVAT Stock